UPDATED Apr 19, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NEWBRY | kr3.50 | 3.6% | -36.4% | kr84.9m | kr8.00 | PS3.7x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
688711 | CN¥25.70 | -4.8% | -66.3% | CN¥3.9b | CN¥97.00 | PE34x | E50.0% | 0.05% | Semiconductors | ||
HHR | AU$0.007 | 0% | -80.6% | AU$22.5m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
A036200 | ₩11,710.00 | 24.8% | 46.9% | ₩349.9b | ₩13,000.00 | PE19.2x | E39.8% | 0.7% | Semiconductors | ||
A211050 | ₩4,900.00 | 0% | 125.8% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance | ||
CAI | AU$0.13 | 4.0% | -42.2% | AU$95.1m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
A439090 | ₩19,060.00 | -1.2% | n/a | ₩312.2b | n/a | PE26.8x | E49.6% | n/a | Household | ||
CALTX | kr100.50 | -2.5% | -20.8% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
AXSM | US$67.90 | -1.8% | -6.9% | US$3.2b | US$121.13 | PS11.9x | E59.8% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$4.52 | -5.8% | -22.9% | US$189.2m | US$19.00 | PS6.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$13.78 | -2.7% | -37.8% | US$2.1b | US$29.75 | PE168.1x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
ERO | CA$27.71 | -2.5% | 5.8% | CA$2.8b | CA$29.20 | PE22.3x | E56.5% | n/a | Materials | ||
GTHX | US$4.11 | -9.7% | 52.2% | US$214.5m | US$8.50 | PS2.6x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$144.41 | -2.8% | -31.0% | US$18.3b | US$220.00 | PS10x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.64 | -12.6% | -39.6% | US$222.9m | US$26.06 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
300820 | CN¥45.82 | -4.9% | -50.9% | CN¥10.1b | CN¥70.67 | PE24.5x | E33.5% | 0.7% | Capital Goods | ||
688390 | CN¥101.06 | -9.4% | -47.9% | CN¥17.5b | CN¥133.61 | PE20.1x | E27.1% | 1.1% | Capital Goods | ||
1830 | HK$2.46 | -21.2% | -37.6% | HK$3.1b | HK$5.89 | PE9.3x | E32.5% | 10.8% | Consumer Services | ||
300442 | CN¥29.20 | 9.1% | -28.7% | CN¥50.2b | CN¥32.19 | PE28.5x | E31.7% | 2.7% | Software | ||
KCB | KSh27.95 | -7.0% | -15.2% | KSh87.2b | KSh51.24 | PB0.4x | E26.0% | 0% | Banks | ||
DIGN | kr1.65 | -8.3% | -62.4% | kr116.3m | kr9.50 | PS1.4x | E139.0% | n/a | Healthcare | ||
CLBIO | kr10.90 | -3.5% | 0% | kr234.2m | kr32.00 | PS6.6x | E71.1% | n/a | Pharmaceuticals & Biotech | ||
ADR | AU$0.029 | -27.5% | -35.6% | AU$9.9m | n/a | PS4.2x | E110.1% | n/a | Healthcare | ||
4071 | ر.س221.40 | -0.7% | 84.5% | ر.س11.1b | ر.س273.50 | PE34.5x | E26.1% | 1.0% | Media |